Yahoo
HKSE - Delayed Quote HKD

Hospital Corporation of China Limited (3869.HK)

3.385 -0.015 (-0.44%)
At close: September 21 at 11:08:40 AM GMT+8
Chart Range Bar
Loading chart for 3869.HK
  • Previous Close 3.400
  • Open 3.400
  • Bid --
  • Ask 3.890 x --
  • Day's Range 3.400 - 3.400
  • 52 Week Range 2.900 - 6.080
  • Volume 400
  • Avg. Volume 0
  • Market Cap (intraday) 462.04M
  • Beta (5Y Monthly) -0.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.020
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Hospital Corporation of China Limited, an investment holding company, owns, operates, and manages hospitals in the People's Republic of China. It operates through three segments: General Hospital Services; Hospital Management Services; and Sale of Pharmaceutical Products. The company offers inpatient and outpatient, operation management, management, supply chain, and other ancillary services to certain hospitals; and property management services. It also engages in the wholesale and retail of pharmaceutical products and medical devices. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China. Hospital Corporation of China Limited operates as a subsidiary of Vanguard Glory Limited.

hcclhealthcare.com

1,835

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

3869.HK
42.63%
HANG SENG INDEX (^HSI)
9.11%

1-Year Return

3869.HK
43.49%
HANG SENG INDEX (^HSI)
11.37%

3-Year Return

3869.HK
51.64%
HANG SENG INDEX (^HSI)
33.83%

5-Year Return

3869.HK
66.15%
HANG SENG INDEX (^HSI)
8.21%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.13%

  • Return on Assets (ttm)

    3.68%

  • Return on Equity (ttm)

    1.74%

  • Revenue (ttm)

    1.46B

  • Net Income Avi to Common (ttm)

    -1.96M

  • Diluted EPS (ttm)

    -0.020

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    862.66M

  • Total Debt/Equity (mrq)

    131.22%

  • Levered Free Cash Flow (ttm)

    27.84M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: